The Report Depression And Seasonal Affective Disorder Therapeutics Market: Global Industry Analysis and Opportunity Assessment 2017-2027 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz
Seasonal Affective Disorder is also referred as winter depression though it comes and goes in the winter season. The symptoms of the seasonal affective disorder often begin in autumn, when the days are getting shorter. This disorder mostly occurs in the month of December, January, and February. This disorder improves and disappears as spring and summer start. Seasonal affective disorder frequently happens due to reducing light exposure to sunlight during winter. The lack of sunlight might result improper working of the hypothalamus which may affect the production of melatonin and serotonin and also affects body’s internal clock.
Get Sample Copy Of This Report @ https://www.marketresearchreports.biz/sample/sample/13144
The symptoms of season affective disorder are persistent loss of mood, irritability, loss of pleasure in doing everyday activities, feeling lethargic and sleepy during day. The seasonal affective disorder can be treated by three methods, psychological treatment, light therapy and medication. In psychological treatment, cognitive behavioral therapy (CBT) and counseling are provided to the patient while light therapy can be done by two types: bright light treatment and dawn simulation. Medication treatment is done by prescribing the antidepressant such as SSRIs. The intake of SSRIs can lead to some side effect such as anxious, upset stomach and diarrhea.
Depression and Seasonal Affective Disorder Therapeutics Market: Drivers and Restraints
The major driving factors for depression and seasonal affective disorder therapeutics market is the rise in geriatric population and change in lifestyle of people. The technological development tends to manufacture of more efficient drugs for the treatment of depression and seasonal affective disorder also responsible for the rapid of this market. The increasing awareness among the people about seasonal affective disorder will propel the growth of this market in developing countries. Favorable reimbursement scenario and more improved distribution network in developed countries will boost the growth of depression and seasonal affective disorder therapeutics market. The growing market for generic drugs and more preference of patient for light therapy will hinder the growth of depression and seasonal affective disorder therapeutics market. The patent expiry for the majority of the drugs and several side effect by consumption of anti-depressant can also restraint the growth of depression and seasonal affective disorder therapeutics market.
Depression and Seasonal Affective Disorder Therapeutics Market: Segmentation
The global depression and seasonal affective disorder therapeutics market is classified on the basis of drug type, distribution channel and geographical region.
Based on drug type, depression and seasonal affective disorder therapeutics market is segmented into following:
- Selective serotonin reuptake inhibitors (SSRIs)
- Norepinephrine-dopamine reuptake inhibitor (NDRI)
- Serotonin and norepinephrine reuptake inhibitors (SNRIs)
- Monoamine oxidase inhibitors (MAOIs)
- Tricyclic antidepressants (TCAs)
Based on distribution channel, depression and seasonal affective disorder therapeutics market is segmented into following:
- Hospital Pharmacies
- Retail Pharmacies and Drug Stores
- Online Pharmacies
Request For TOC @ https://www.marketresearchreports.biz/sample/toc/13144
Depression and Seasonal Affective Disorder Therapeutics Market: Overview
Depression and seasonal affective disorder therapeutics market is expected to show substantial growth over the forecast period. According to survey published in SAGE Publication, 10 % of U.S. population suffers from the seasonal affective disorder. Depression and seasonal affective disorder therapeutics market can be classified on the basis of drug therapy and distribution channel. Based on depression and seasonal affective disorder therapeutics market is classified as selective serotonin reuptake inhibitors, norepinephrine-dopamine reuptake inhibitor, serotonin and norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, tricyclic antidepressants and other. The selective serotonin reuptake inhibitors are expected to dominate the major market in term of value over the forecast period. The major brands of SSRI’s which are dominating the on depression and seasonal affective disorder therapeutics market are Citalopram, Escitalopram, Fluoxetine, and Sertraline.
Depression and Seasonal Affective Disorder Therapeutics Market: Regional Overview
On the basis of geographical region the depression and seasonal affective disorder therapeutics market is segmented into seven key regions, viz. North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan and Middle East & Africa. North America is expected to dominate the global depression and seasonal affective disorder therapeutics market due to a large number of population suffering from the seasonal affective disorder. After North America, depression and seasonal affective disorder therapeutics market is followed by Western Europe owing to advancement in technology and development of new drugs. In APEJ region India and China is will dominate the depression and seasonal affective disorder therapeutics market due to rise in geriatric population.
Depression and Seasonal Affective Disorder Therapeutics Market: Key Players
Examples of some of the market participants in depression and seasonal affective disorder therapeutics market identified across the value chain include Janssen Pharmaceutical Inc., Pfizer Inc., Merck & Co., GlaxoSmithKline plc, Sanofi S.A., Eli Lilly and Company, Biogen Idec., Bristol-Myers Sqibb, Baxter Healthcare Corporation, Novartis AG, Shire plc, AstraZenecaplc.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico. Brazil)
- Western Europe (Germany, Italy, France, U.K, Spain)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Middle East and Africa (GCC Countries, S. Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207